After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for…
Post-traumatic stress disorder
FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study
WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a…
FDA won't approve the psychedelic drug MDMA for PTSD, calling for more research on its safety and effectiveness
FDA won’t approve the psychedelic drug MDMA for PTSD, calling for more research on its safety…